RxDoctor Payments Data

Robert Camara, DO

Family Medicine · Howell, MINPI 1942207931

Payments from drug & device makers

$195in general payments, 2019–2025

Across 15 payments — averaging $13.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$65
  • Novo Nordisk$27
  • Johnson & Johnson$24
  • Astellas Pharma US Inc$17
  • Teva Pharmaceuticals USA, Inc.$15
  • Amgen$13
  • plus $35 from 3 others

What the payments were for

  • Food & beverage$195100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$195 in reported general payments places this provider in the 45th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$90,763
Medicare patients
297
Services billed
1,391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban152$195,190
JanuviaSitagliptin Phosphate139$184,659
XareltoRivaroxaban59$60,805
JardianceEmpagliflozin25$39,084
OzempicSemaglutide13$29,103
FarxigaDapagliflozin Propanediol16$25,861
InvokanaCanagliflozin21$22,921
Lantus SolostarInsulin Glargine,hum.Rec.Anlog76$18,013
LinzessLinaclotide22$15,673
Atorvastatin Calcium786$10,273
Fluticasone-SalmeterolFluticasone Propion/Salmeterol41$9,667
Ezetimibe306$6,729
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$6,583
Levemir FlexpenInsulin Detemir16$6,327
Levothyroxine Sodium527$6,280

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$65$200,636171 claims
MerckJanuvia$11$184,659139 claims
Johnson & JohnsonXarelto, Invokana$24$83,72680 claims
Boehringer IngelheimJardiance$12$39,08425 claims
Novo NordiskOzempic$27$29,10313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Howell

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →